Skip to main content

The 2018 Farm Bill took industrial hemp and hemp products off the controlled substances list, and now government departments are scrambling to bring their policies up to date. The FDA no longer has general authority over the product. The USDA is now responsible for the oversight of the plants, but the Federal Food, Drug, and Cosmetic Act (FD&C Act) means the FDA remains responsible for overseeing any products released with medical claims, or as food or cosmetics. The FDA has had to shift from a complete prohibition paradigm, to more of an open policy, and there is confusion in the Capital

FDA CBD Gummies

Companies are now cashing in on consumers’ new curiosity, and consumers are experimenting with every product they can get their hands on.

Before the FDA policies could catch up with the changing laws, an explosion of products hit the market. Companies are now cashing in on consumers’ new curiosity, and consumers are experimenting with every product they can get their hands on, like CBD gummies from Verma Farms. Now, the FDA is struggling to put the brakes on a market that raises concerns for them, and that market seems to be spiraling wildy out of control.

There are a couple of different angles we could take from this point forward. One is that the FDA is doing its best to protect American citizens, and because this government agency wants us to have access to good, safe food and medicine, they require loads of research in order to approve anything we ingest. There is not enough research to support medical claims, plus CBD may not be entirely safe, so the FDA is doing its job by not allowing CBD brands to educate consumers about the health benefits of CBD gummies.

The other angle, is that the FDA has been hand-in-hand with Big Pharma forever, they are not actually that concerned about our safety (look at the blind eye they took to the outrageous availability of opioids, leading to an epidemic affecting generations), and that the stopgap is so they can figure out a way to make CBD into an array of expensive drugs.

The FDA, Benevolent Guardian

People may have been using cannabis to treat ailments and support overall health for thousands of years, but because it has been illegal since 1937, there is not much modern scientific research about its effects. Even though the craze over the medicinal properties of cannabis is upon us, it will take years for scientific studies to catch up. We still do not know the exact mechanisms by which CBD works, therefore, we do not know how it supports our biology. We also do not know what the long-term effects of its use are. Is there a cumulative effect? If so, does it do damage to any of our organs over time? There is some evidence that prolonged use may cause some sort of liver injury, but the specifics of that conclusion are not clear.

By banning medical claims on advertising, the FDA is protecting Americans from falling into the trap of bad health advice. They do not want people putting off going to the doctor, trying to treat serious illnesses with CBD, and potentially making the illness worse for lack of treatment.

The FDA is just trying to keep up. The prohibition on marijuana has been losing popularity, and its medical use has proven effective for several conditions. Sativex, a THC, CBD combination drug, is currently approved for use in Europe and Canada, and people are hungry for alternative medicines that are not addictive and do not make them feel ill. The Federal Government legalized industrial hemp for economic and agricultural reasons, and the timing is converging for a green explosion.

Scroll to Continue

Recommended Articles

The FDA has since taken a stance that they reserve the right to go after companies that do interstate business selling CBD as food, or with medical, dietary, or supplemental claims. They recently released a statement that they will focus on products purported to prevent, treat, improve, or cure serious diseases such as cancer, Alzheimer’s disease, psychiatric disorders and diabetes. This seems like a reasonable stance, because some people may not get proper treatment for serious illnesses if they are treating them with CBD.

The FDA and the Big Pharma Lobby

The FDA turned a blind eye while the opioid industry got millions of people hooked on their drugs. People are currently dying every day, either from an overdose, or the dirty street drugs they sought after their prescription ran out.

In addition, rising medical costs bankrupt families and they cannot afford to pay for expensive medicines that treat their cancer, Alzheimer’s disease, psychiatric disorders, and diabetes. These are some of the most common and the most expensive disorders and diseases to treat,

and people have died because they cannot afford to buy their medicine.

This is not to say that consumers should throw away their prescriptions and cancel their checkups. More so that the FDA is less concerned about our health, and more concerned about profits to be gained. Should you keep taking your insulin? Yes. Should you give CBD a try? Yes. You should be able to work closely with your doctor to monitor results, and they should be able to give you medical advice related to your use.

You should also be able to afford going to your doctor. Those who cannot afford a doctor should have access to alternatives. CBD could end up being a lifesaving or at least life improving treatment for people who would otherwise get no medical treatment.

There is a growing body of research indicating that CBD has powerful anti inflammatory and neuroprotective properties. Since inflammation is believed to be behind many known diseases, what is the holdup in getting CBD on the list of substances used to treat chronic pain, neurodegenerative, and inflammatory diseases? Maybe it is because the FDA is waiting for Big Pharma to make it into an expensive drug. That way, they can cover for the financial loss of people no longer using opioids, NSAIDs, and expensive neuroprotective drugs.

Final Thoughts

In the end, the truth about the FDA’s intentions probably lies somewhere in between the two polar views. Bits of truth can be found on both sides, and where the CBD stance lands is a matter of politics as usual. Regulation will probably be unstable for several years to come, so it is up to the consumer to do the research and decide how they will use CBD. The National Center for Biotechnology Information is a great resource for anyone interested in learning more about the effects of CBD.